Nervous System Diseases Clinical Trial
Official title:
Cost/Utility Ratio in the Management of Patients With Acquired Severe Brain Injury: Comparison Between a Programme of In-hospital Graded Intensity Rehabilitation and Usual Care.
The aim of this study was to compare the cost/utility ratio of a management model of integrated, graded, intensive rehabilitation (GIR) versus usual care (UC) for patients with acquired Severe Brain Injury (SBI).
Materials and methods Study design This study was an organizational assessment of an
integrated system of care (GIR) for patients with SBI and was designed as a prospective,
randomised trial. An individual record was created for each patient with SBI; this record
contained the patient's personal data, information prior to admission to intensive care or
neurosurgery, clinical characteristics, the presence of devices, complications, time of
hospitalisation in an Intensive Care Unit, and cognitive conditions. Once it had been
determined that the study entry criteria were met, the patients were entered in the register
and prospectively in parallel-group randomised to two different management strategies.
The concealment of allocation was guaranteed by the availability of beds in the ward.
Patients and health care providers and assessors were blinded to the study designed to
compare the strategies management. Data analysts were blinded to treatment.
Sample size The sample size requirements for this study are intended to provide adequate
power for the analysis of the primary objective ( decrease event-related mortality). The
simulation were run in statsoft six sigma software according to the following hypotheses:
the mortality of severe brain injury used as a Null hypothesis was 58%. This percent value
is expected to decrease at 40% in the study arm. The target type-I error(α) was 0.05. A
sample size of 119 patients per group would allow a power of 80% to detect an individual
risk score ratio of 0.70 with a type -I error of 0.05.
Based on the availability of beds in the ward, two groups were formed:
(i) the UC patients who, while meeting the criteria for access into the Graded Intensity of
Rehabilitation Unit for patients with SBI (SBI-GIRU), did not enter the department because
no beds were free and were, therefore, discharged from the Intensive Care Unit into the
management models available, such as acute care, Intensive Brain Injury rehabilitation ( cod
75) brain injury rehabilitation (code 56) ( hospital admission, lasting on average 60 days,
in which intensive rehabilitation care is delivered prior to transfer to another structure),
long-term care, home.
(ii) The GIR patients who met the criteria for access into the SBI-GIRU and for whom a bed
was available in the Unit, where an individualised programme of intensive rehabilitation
care was structured.
The primary outcome for assessing the effectiveness of the two different forms of management
was mortality; secondary outcomes included the improvement of quality of life evaluated
using a classification system based on the Health Utilities Index Mark 2 (8) and the number
of days of hospitalisation.
Patients Patients with acquired SBI referred to our unit between January 2007 and January
2010 were considered for this study. The diagnosis of acquired SBI was made on the basis of
the clinical history, physical examination, clinical symptoms, Glasgow Coma Scale score <8
and neuro-radiological investigations.
After having been entered into the register, patients in the UC group began the monitoring
phase, while the patients in the GIR group were submitted to clinical evaluation, prognostic
stratification, and clinical and instrumental investigations, after which an individualised
rehabilitation plan was made, characterized by structured multidisciplinary interventions
that were periodically reviewed. The alternative management strategies are described in
greater detail below.
Usual care In this case patients were managed according to the organization of the
management model which took on the care of the patient. The organization of these models is
characterized by one or two professional figures (physiatrists, neurologist), with
hierarchical relationships, in spaces limited to a specific pathology; access is determined
by clinical stability; the instruments of governance are guidelines and consensus and the
rehabilitation programme is focused on functional and cognitive areas; the medical care
process is governed by hierarchy. The technology in this model is limited to a specific
specialty.
Graded intensive rehabilitation This is a result-oriented management model; it is
multidisciplinary and has the purpose of determining the appropriateness of hospitalization
and the patients' needs through the use of a ranking; the management is "disease-based", and
the instruments of governance are the diagnostic-therapeutic rehabilitation pathways (DTRP),
the quality system and product standards; the medical care process has separate strands with
result-oriented autonomy; the technology present in this model is identified on the basis of
health needs and support of vital signs.
Classifying patients In relation to their clinical conditions and complexity of care needs,
three profiles of patients with SBI have been identified: the critically patient, the
complex patient and the frail patient. The critically ill patient is a patient with abnormal
vital parameters who requires constant monitoring and may need immediate therapeutic
interventions. The complex patient is an individual with significant comorbidities who
requires complicated, expensive and often invasive diagnostic investigations and/or numerous
therapies sometimes conflicting with each other with a strong risk of interactions. The
complexity of care increases in "frail patients". Frail patients have: (i) a marked
susceptibility to develop acute illnesses that are manifested by atypical clinical
pictures;(ii) rapid fluctuations of health, even in the same day, with a strong tendency to
develop complications (failure cascade); (iii) a high risk of adverse events and iatrogenic
events; (iv) slow and, almost always, only partial recovery; (v) continued requirements for
medical interventions, need for ongoing assistance; and (vi) a high risk of mortality.
Levels of intensity of care On the basis of the above-described evaluation, the patient is
assigned to the most appropriate of the following settings.
Level 1 (intensive): the patient is critical and unstable, dependent or potentially
dependent on technological aids and at high risk of complications. Area of competence - red:
monitored beds, single rooms, infusion pumps, telemetry, daily medical round, and intensive
nursing activities 24 hours a day.
Level 2 (medium): the patient is clinically unstable and requires constant monitoring of
vital parameters. Highly complex medical activities and intensive nursing care are
prevalent. Area of competence - yellow: rooms with two beds, infusion pumps, telemetry,
daily medical round, intensive, structured nursing activities, physiotherapy and speech
therapy.
Level 3 (low): the patient is clinically stable and does not require constant monitoring of
vital signs or the continuous presence of a doctor. Activities are prevalently physiotherapy
and nursing care. Area of competence - green.
Level 4 (minimum): the patient is clinically stable and requires only social and nursing
care for discharge. Area of competence - white.
The transition between different levels is determined by clinical criteria that define the
area of competence required.
Staff The staff of the SBI-GIRU consists of a neurologist, an internist, a physiatrist, a
cardiologist, a speech physician, twelve nurses with specific skills, a chief nurse, a
nutritionist, two speech therapists, three physiotherapists, a psychologist and a social
worker. The aim of the multidisciplinary approach is to facilitate recovery from disability
caused by SBI.
Each member of the team has the duty to control, analyse and redesign the organization that
supports the activities and processes set out in the individual rehabilitation plan. Three
types of intervention - medical, nursing and physiotherapeutic - can be identified in the
rehabilitation plan and are strongly integrated in order to achieve the rehabilitation
objectives. The healthcare and rehabilitation processes are founded on guidelines and the
criteria of evidence-based medicine.
The rehabilitation process The treatment plan is discussed in collaboration with the whole
multidisciplinary team. An individual rehabilitation plan is drawn up which outlines: (i)
the appropriateness of access; (ii) the type of access (SBI of traumatic, anoxic one,
ischaemic or haemorrhagic nature); (iii) the objectives of the rehabilitation process
(prognostic stratification, therapy optimization, prevention of secondary injury, management
of devices, management of cognitive impairment, prevention of damage by immobility, recovery
of motor function); (iv) use of the instruments to implement the plan (multi-disciplinary
meeting, electroencephalogram, physiotherapy briefings, diagnostic radiology, consultancy,
monitoring systems, infusion systems); (v) time-course of the plan; (vi) result indicators
in the short to medium term; (vii) results indicators in the long-term; (viii) the method of
discharge; and (ix) management counselling.
Follow-up A monitoring form was used for each patient to record the following information:
personal data, outcome measures, employment issues, degree of socialisation, commitment of
caregivers and the results of the Health Utilities Index Mark 2 questionnaire.
Outcomes Three types of outcomes were considered: management outcomes, functional results
and a hard end-point (survival).
Management outcomes. The management outcomes considered were: access time, number of
structures involved in the management of the patient, the healthcare path, the number of
days spent in hospital, the type of management to which the patient was subsequently
addressed.
Functional results. These included the number of devices at discharge, the Glasgow Outcome
Scale (GOS) score, the Barthel Index score and any change in quality of life, assessed using
the classification system based on the Health Utilities Index Mark 2 Survival. The patient's
death related to the event index was considered as a hard event. In the survival analysis
the two management models were considered as predictors of mortality. These predictors were
adjusted for confounding variables (age, sex, aetiology, GOS score, Level of Cognitive
Functioning score and indices of organ function). The association between independent
predictors and outcome was assessed by comparing the follow-up data with a Cox proportional
hazards regression model. The end-point of the study was event-related mortality. The
distribution of the time function of the events was analysed with the Kaplan-Meier method
Cost analysis The cost/utility analysis was performed from the payer's prospective (the
health authority). Hospital admissions for the implementation of the process and for health
care - in particular, admissions to intensive care, acute care, rehabilitation and the
social welfare sector - were considered. Management costs incurred at home were excluded.
The prices used for calculations were those of the average daily cost of hospitalisation per
type of management as listed in the Interregional Tariff Agreement [Tariffa Unica
Convenzionale, TUC] 2009 for hospital healthcare services. The QALY was determined by
calculating the years of life gained in management models adjusted for the quality of life.
The difference in QALYs between the two models was obtained by considering the average
increase of life derived from the survival curves (difference between the areas of the
survival curves) adjusted for the quality of life.
Sensitivity analysis The sensitivity analysis was performed by calculating the cost/utility
ratio using the extremes; in particular, changes in QALY and costs were evaluated by
considering the extremes (confidence limits of the variations of the mean).
Statistical analysis To compare the clinical and functional parameters between the two
groups we used the one-way analysis of variance for continuous variables and chi-square
tests for categorical variables. For the analysis of prognostic indicators, the two
management strategies were considered as independent predictors of outcome. The analysis was
adjusted for confounding factors. event-related mortality was considered as an end-point of
the study.
The association between independent predictors and outcome was assessed by comparing the
follow-up data with a Cox proportional hazards regression model. The assumption of the
proportionality of risk during the observation time, has been evaluated using the analysis
of residues of Schoenfeld. Deaths from causes unrelated to the SBI were treated as censored
observations. The distribution of the time function of the events was analysed using the
method of Kaplan-Meier. The prognostic information is presented as relative risk with 95%
confidence limits. Descriptive statistics are expressed as the mean value ± standard
deviation. Probability values <0.05 are considered statistically significant.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05086809 -
Investigation of an Updated Bone-anchored Sound Processor
|
N/A | |
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Recruiting |
NCT03222375 -
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT01922258 -
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Active, not recruiting |
NCT03911388 -
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
|
Phase 1 | |
Completed |
NCT02798406 -
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
|
Phase 2 | |
Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
Completed |
NCT03994822 -
pRESET for Occlusive Stroke Treatment
|
N/A | |
Completed |
NCT03336645 -
Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan
|
Phase 3 | |
Completed |
NCT04283253 -
Predictors of Response in Chronic Stroke
|
N/A | |
Not yet recruiting |
NCT06048523 -
Prospective Cohort Study of Neurogenetic Diseases
|
N/A | |
Completed |
NCT02684825 -
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
|
N/A | |
Active, not recruiting |
NCT02284126 -
Topical Vancomycin for Neurosurgery Wound Prophylaxis
|
Phase 3 | |
Completed |
NCT05815836 -
Precision Medicine in Stroke
|
||
Completed |
NCT00739518 -
Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
|
N/A | |
Recruiting |
NCT03678194 -
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
|
N/A | |
Recruiting |
NCT04698421 -
Collection of Biological Samples From Patients With Rare Neurological Diseases
|